Evidence map›Paper›PMID 35134315›Full record

ReviewAnnual review of immunology2022

Distinct Cellular Tropism and Immune Responses to Alphavirus Infection.

Natasha M Kafai, Michael S Diamond, Julie M Fox

Abstract readReview
In one paragraph

Review in Annual review of immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. IFN-κ directs antiviral immunity in human skin.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Viral interference of nucleocytoplasmic transport.The Journal of biological chemistry · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natasha M KafaiDepartment of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA; email: natasha.kafai@wustl.edu, mdiamond@wustl.edu.
Michael S DiamondDepartment of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA; email: natasha.kafai@wustl.edu, mdiamond@wustl.edu.
Julie M FoxLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA; email: julie.fox@nih.gov.

Funding

Specific and Broadly Active Monoclonal Antibody Therapeutics Against The FilovirusesU19AI142790 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SAPHIRE, ERICA OLLMANN · 2019 to 2023
$40.0M
Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
Mechanisms of immune-mediated protection and pathogenesis during viral infectionsZIAAI001348 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FOX, JULIE · 2021 to 2025
$7.4M
Structure-Function Analysis of Mxra8 Interaction with Alphaviruses.R01AI143673 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FREMONT, DAVED H. · 2019 to 2025
$6.5M
LDLRAD3 Receptor Interaction with Venezuelan Equine Encephalitis VirusR01AI164653 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FREMONT, DAVED H. · 2021 to 2025
$3.8M
Gut Microbiota Modulation of Chikungunya Virus Infection and PathogenesisR01AI152484 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FISCHBACH, MICHAEL ANDREW · 2021 to 2025
$3.2M
Impairment of B cell Responses by Pathogenic Chikungunya VirusesR01AI141436 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DIAMOND, MICHAEL S, MORRISON, THOMAS E · 2019 to 2023
$3.2M
IFN Dependent Control of Acute and Chronic Chikungunya Virus Induced DiseaseR01AI127513 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, LENSCHOW, DEBORAH J · 2017 to 2020
$2.1M
NIAID NIH HHS R01 AI127513NIAID NIH HHS R01 AI141436NIAID NIH HHS R01 AI143673NIAID NIH HHS R01 AI152484NIAID NIH HHS R01 AI164653NIAID NIH HHS T32 AI007172NIAID NIH HHS U19 AI142790
6 · The paper itself

Abstract

Alphaviruses are emerging and reemerging viruses that cause disease syndromes ranging from incapacitating arthritis to potentially fatal encephalitis. While infection by arthritogenic and encephalitic alphaviruses results in distinct clinical manifestations, both virus groups induce robust innate and adaptive immune responses. However, differences in cellular tropism, type I interferon induction, immune cell recruitment, and B and T cell responses result in differential disease progression and outcome. In this review, we discuss aspects of immune responses that contribute to protective or pathogenic outcomes after alphavirus infection.

Indexed as

AlphavirusAlphavirus InfectionsInterferon Type IAnimalsHumansImmunityTropismInterferon Type Ialphavirusarbovirusimmunitymouse modelspathogenesistropism

Identifiers

PMID35134315
PMCPMC10350340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.